MICHAEL SETH ALTMAN
CIK 1746738 · Chief Financial Officer · last filed 2024-07-31
MICHAEL SETH ALTMAN is a Chief Financial Officer who has filed 15 SEC Form 4 insider transactions across 7 companies since 2020. The most recent filing, for ARYD, was dated Jul 31, 2024. Current disclosed insider exposure totals $3.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.26M
7
15
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARYA Sciences Acquisition Corp IV (ARYD) Delisted | Chief Financial Officer | 0 | $6.64 | $0 | $0 | 2 | 2024-07-31 |
| NAUT | Director | 0 | $2.24 | $0 | $0 | 4 | 2024-06-17 |
| LYRA | Director | — | $0.70 | — | $0 | 5 | 2024-06-14 |
| PCSC | Chief Business Officer | 286,250 | $11.40 | $3.26M | $0 | 1 | 2024-06-13 |
| ARYA Sciences Acquisition Corp V (ARYE) Delisted | Chief Financial Officer | 499,000 | $10.36 | $5.17M | $0 | 1 | 2021-07-15 |
| Nautilus Biotechnology, Inc. (ARYA) Delisted | Chief Financial Officer | 499,000 | $11.16 | $5.57M | $0 | 1 | 2020-08-11 |
| Cerevel Therapeutics Holdings, Inc. (CATB) Delisted | Chief Financial Officer | 499,000 | $8.54 | $4.26M | $0 | 1 | 2020-06-09 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-07-31 | ARYA Sciences Acquisition Corp IV (ARYD) Delisted | Disp (D) | −499,000 | $0 | EDGAR |
| 2024-06-17 | NAUT | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | LYRA | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | PCSC | Grant (A) | +286,250 | $2.86M | EDGAR |
| 2023-07-05 | LYRA | Grant (A) | — | $0 | EDGAR |
| 2023-06-20 | NAUT | Grant (A) | — | $0 | EDGAR |
| 2022-06-21 | LYRA | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | NAUT | Grant (A) | — | $0 | EDGAR |
| 2021-07-15 | ARYA Sciences Acquisition Corp V (ARYE) Delisted | Grant (A) | +499,000 | $4.99M | EDGAR |
| 2021-06-11 | NAUT | Mixed | +3,647,500 | $0 | EDGAR |